Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The TT/DHT ratio may help identify PCOS patients with severe metabolic issues.

Women with PCOS often have different clinical signs, hormone levels, and gynecological issues compared to those without the condition.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Dye mainly stays on the hair surface and endocuticle.

PBM helps improve cell survival in 3D tissue engineering.

PTeCA is a reliable marker for detecting oxidative hair treatments.

Polish medical societies recommend personalized treatment for PCOS based on the patient's specific symptoms and use the Rotterdam criteria for diagnosis.

Pregnancy and parenthood may help regulate PCOS symptoms.

Loss of Fz6 disrupts hair follicle and associated structures' orientation.

PCOS is now seen as a complex metabolic and hormonal disorder called PMOS.

The new microscope method helps study energy from pre-cancerous skin cells.

PCOS should be redefined as PMOS to better address its complex metabolic issues and improve treatment.

A combined medical and aesthetic approach is crucial for effectively managing PCOS and its skin-related issues.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

3D models from confocal microscopy improve melanoma detection on sun-damaged skin.

PCOS shares similar genetic traits across different diagnosis criteria and is linked to other health conditions.

Women with and without PCOS show no significant differences in psychopathic traits.

Reflectance confocal microscopy is a useful, non-invasive tool for diagnosing some skin diseases, with potential for future improvements.

Dermoscopy helps dermatologists diagnose different types of hair loss accurately without always needing a biopsy.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

New methods for identifying and managing polycystic ovary syndrome in teenagers are improving.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Skin issues in women with PCOS are linked to hormone imbalances and can help diagnose the condition early.

3D imaging of skin biopsies offers better accuracy but is time-consuming and can't clear melanin.

Olmsted syndrome can be inherited as an autosomal recessive trait due to a rare TRPV3 gene mutation.

Skin of color can spontaneously repigment after a phenol-croton oil chemical peel.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.